DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

13.47 -0.01 (-0.07%)

Streaming Delayed Price Updated: 9:32 AM EDT, Aug 10, 2026 Add to My Watchlist

Price and Volume

Volume	14,771
Open	13.46
Bid (Size)	13.42 (2,000)
Ask (Size)	13.59 (400)
Prev. Close	13.48
Today's Range	13.45 - 13.47
52wk Range	8.700 - 26.18
Shares Outstanding	55,096,537
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq

July 30, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales

July 17, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Performance

YTD	-29.3%	-29.3%
1 Month	-18.3%	-18.3%
3 Month	-33.8%	-33.8%
6 Month	-39.4%	-39.4%
1 Year	+38.2%	+38.2%

More News

DBV Technologies Q2 Earnings Call Highlights ↗

July 16, 2026

Via MarketBeat

DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Report

July 16, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update

July 16, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026

July 14, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

July 06, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

June 29, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index

June 23, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

June 09, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026

June 08, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

June 05, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026

June 03, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces the Results of its 2026 Combined General Meeting

June 03, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy

June 02, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Combined General Meeting of June 3, 2026

May 13, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq

May 12, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Reports First Quarter 2026 Financial Results

April 30, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026

April 02, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

March 26, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Reports Full Year 2025 Financial Results and Business Update

March 26, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

March 24, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in Upcoming March Investor Conferences

March 04, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

March 03, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting

February 28, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Frequently Asked Questions

Is DBV Technologies S.A. - American Depositary Shares publicly traded?

Yes, DBV Technologies S.A. - American Depositary Shares is publicly traded.

What exchange does DBV Technologies S.A. - American Depositary Shares trade on?

DBV Technologies S.A. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for DBV Technologies S.A. - American Depositary Shares?

The ticker symbol for DBV Technologies S.A. - American Depositary Shares is DBVT on the Nasdaq Stock Market

What is the current price of DBV Technologies S.A. - American Depositary Shares?

The current price of DBV Technologies S.A. - American Depositary Shares is 13.47

When was DBV Technologies S.A. - American Depositary Shares last traded?

The last trade of DBV Technologies S.A. - American Depositary Shares was at 08/10/26 09:32 AM ET

What is the market capitalization of DBV Technologies S.A. - American Depositary Shares?

The market capitalization of DBV Technologies S.A. - American Depositary Shares is 742.15M

How many shares of DBV Technologies S.A. - American Depositary Shares are outstanding?

DBV Technologies S.A. - American Depositary Shares has 742M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.